⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACHV News
Achieve Life Sciences, Inc.
Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program
globenewswire.com
ACHV
Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation
globenewswire.com
ACHV
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025
globenewswire.com
ACHV
Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation
globenewswire.com
ACHV
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
globenewswire.com
ACHV